Trials / Conditions / Methamphetamine Induced Psychosis
Methamphetamine Induced Psychosis
7 registered clinical trials studyying Methamphetamine Induced Psychosis — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Us NCT07459270 | Elazığ Mental Health and Diseases Hospital | — |
| Not Yet Recruiting | This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinic NCT07184710 | Sohag University | — |
| Recruiting | LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis NCT07450027 | Elazığ Mental Health and Diseases Hospital | — |
| Completed | α-N-acetylgalactosaminidase in Methamphetamine Psychosis NCT07434401 | Elazığ Mental Health and Diseases Hospital | — |
| Recruiting | ECG Findings in Methamphetamine Use NCT07459244 | Elazığ Mental Health and Diseases Hospital | — |
| Recruiting | Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis NCT07459257 | Elazığ Mental Health and Diseases Hospital | — |
| Completed | Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis NCT01939093 | Chulalongkorn University | Phase 4 |